INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 426m ago
HOUSE PTR26m ago
SEC 13F26m ago
ROBINHOOD CHAIN25m ago
Public company

NGNENeurogene Inc.

CIK 0001404644

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 1
Max Insider Score21
Connections5with evidence

NGNE · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SC
Shafer ChristinaChief Commercial Officer
NGNENeurogene Inc.
Grant or award
A—
120.0K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Shafer ChristinaChief Commercial Officer · May 7, 2026
  • ← Insider ofevidence
    Woods KeithDirector · Feb 24, 2026
  • ← Insider ofevidence
    Cobb StuartChief Scientific Officer · Feb 24, 2026
9
JJ
Jordan JulieChief Medical Officer
NGNENeurogene Inc.
Open-market sale · 10b5-1 plan
SELL
$18K
828 sh
Mar 26, 2026
Mar 30, 2026
traded Mar 26, 2026
+4d
SEC FORM 4

Evidence

9
WK
Woods KeithDirector
NGNENeurogene Inc.
Grant or award
A—
12.1K sh
Feb 20, 2026Feb 24, 2026
traded Feb 20, 2026
+4dSEC FORM 4

Evidence

21
CS
Cobb StuartChief Scientific Officer
NGNENeurogene Inc.
Grant or award
A—
16.5K sh
Feb 20, 2026Feb 24, 2026
traded Feb 20, 2026
+4dSEC FORM 4

Evidence

21
JJ
Jordan JulieChief Medical Officer
NGNENeurogene Inc.
Grant or award
A—
4,900 sh
Feb 20, 2026Feb 24, 2026
traded Feb 20, 2026
+4dSEC FORM 4

Evidence

9
JJ
Jordan JulieChief Medical Officer
NGNENeurogene Inc.
Grant or award
A—
29.6K sh
Feb 20, 2026Feb 24, 2026
traded Feb 20, 2026
+4dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Jordan JulieChief Medical Officer · Feb 24, 2026